David Benjamin Mark Ganetzky, MD - Medicare Family Practice in Philadelphia, PA

David Benjamin Mark Ganetzky, MD is a medicare enrolled "Family Medicine" physician in Philadelphia, Pennsylvania. He went to Clvlnd Clinic Lerner College Of Med Of Case Wstn Rsv University and graduated in 2010 and has 14 years of diverse experience with area of expertise as Family Practice. He is a member of the group practice University Of Penn - Medical Group and his current practice location is 51 N 39th St, 7 Floor Mutch Bldg, Philadelphia, Pennsylvania. You can reach out to his office (for appointments etc.) via phone at (215) 662-8777.

David Benjamin Mark Ganetzky is licensed to practice in Pennsylvania (license number MD448727) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1043539539.

Contact Information

David Benjamin Mark Ganetzky, MD
51 N 39th St, 7 Floor Mutch Bldg,
Philadelphia, PA 19104-2640
(215) 662-8777
Not Available



Physician's Profile

Full NameDavid Benjamin Mark Ganetzky
GenderMale
SpecialityFamily Practice
Experience14 Years
Location51 N 39th St, Philadelphia, Pennsylvania
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • David Benjamin Mark Ganetzky attended and graduated from Clvlnd Clinic Lerner College Of Med Of Case Wstn Rsv University in 2010
  NPI Data:
  • NPI Number: 1043539539
  • Provider Enumeration Date: 05/24/2010
  • Last Update Date: 05/22/2013
  Medicare PECOS Information:
  • PECOS PAC ID: 4082855473
  • Enrollment ID: I20130727000134

Medical Identifiers

Medical identifiers for David Benjamin Mark Ganetzky such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1043539539NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine MD448727 (Pennsylvania)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Penn Medicine Home HealthBala cynwyd, PAHome health agency
Penn Presbyterian Medical CenterPhiladelphia, PAHospital
Hospital Of Univ Of PennsylvaniaPhiladelphia, PAHospital
Pennsylvania HospitalPhiladelphia, PAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
University Of Penn - Medical Group62047309553031

News Archive

Protein profiling reveals new prostate cancer mechanisms

A study by the University of Tampere in Finland used protein profiling to find new prostate cancer mechanisms that are not shown by aberrations at the genomic level. Several new potential biomarkers of prostate cancer were also found.

Researchers develop experimental protocol to detect age-related memory disorders

By studying the aging of memory in the mouse, researchers in the Laboratoire Neurobiologie des Processus Adaptatifs have developed an experimental protocol that can detect age-related memory deficits at an early stage. They have shown that even at 10 months, which corresponds to a third of their life expectancy, some mice present with age-related memory disorders.

Cal-EPA intents to add BPA to state's list of chemicals known to cause cancer

The California Environmental Protection Agency signaled intent to add bisphenol A (BPA) to the state's list of chemicals known to cause cancer or birth defects, adding to evidence the chemical should be banned from food and beverage containers.

Alchemia's HyACT tumour targeting technology enhances killing of cancer stem cells

Alchemia's subsidiary Alchemia Oncology today presented two posters at the American Association of Cancer Research (AACR) 101st Annual Meeting in Washington, DC. The data demonstrates the ability of the Company's HyACT tumour targeting technology to dramatically enhance the killing of cancer stem cells. These cells are highly resistant to treatment with chemotherapeutic drugs and are believed to be responsible for treatment failure and disease recurrence.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. David Benjamin Mark Ganetzky allows following entities to bill medicare on his behalf.
Entity NameUniversity Of Penn - Medical Group
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1235527342
PECOS PAC ID: 6204730955
Enrollment ID: O20141111000091

News Archive

Protein profiling reveals new prostate cancer mechanisms

A study by the University of Tampere in Finland used protein profiling to find new prostate cancer mechanisms that are not shown by aberrations at the genomic level. Several new potential biomarkers of prostate cancer were also found.

Researchers develop experimental protocol to detect age-related memory disorders

By studying the aging of memory in the mouse, researchers in the Laboratoire Neurobiologie des Processus Adaptatifs have developed an experimental protocol that can detect age-related memory deficits at an early stage. They have shown that even at 10 months, which corresponds to a third of their life expectancy, some mice present with age-related memory disorders.

Cal-EPA intents to add BPA to state's list of chemicals known to cause cancer

The California Environmental Protection Agency signaled intent to add bisphenol A (BPA) to the state's list of chemicals known to cause cancer or birth defects, adding to evidence the chemical should be banned from food and beverage containers.

Alchemia's HyACT tumour targeting technology enhances killing of cancer stem cells

Alchemia's subsidiary Alchemia Oncology today presented two posters at the American Association of Cancer Research (AACR) 101st Annual Meeting in Washington, DC. The data demonstrates the ability of the Company's HyACT tumour targeting technology to dramatically enhance the killing of cancer stem cells. These cells are highly resistant to treatment with chemotherapeutic drugs and are believed to be responsible for treatment failure and disease recurrence.

Read more Medical News

› Verified 6 days ago

Entity NameUniversity Of Penn - Medical Group
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1053447151
PECOS PAC ID: 6204730955
Enrollment ID: O20150304001436

News Archive

Protein profiling reveals new prostate cancer mechanisms

A study by the University of Tampere in Finland used protein profiling to find new prostate cancer mechanisms that are not shown by aberrations at the genomic level. Several new potential biomarkers of prostate cancer were also found.

Researchers develop experimental protocol to detect age-related memory disorders

By studying the aging of memory in the mouse, researchers in the Laboratoire Neurobiologie des Processus Adaptatifs have developed an experimental protocol that can detect age-related memory deficits at an early stage. They have shown that even at 10 months, which corresponds to a third of their life expectancy, some mice present with age-related memory disorders.

Cal-EPA intents to add BPA to state's list of chemicals known to cause cancer

The California Environmental Protection Agency signaled intent to add bisphenol A (BPA) to the state's list of chemicals known to cause cancer or birth defects, adding to evidence the chemical should be banned from food and beverage containers.

Alchemia's HyACT tumour targeting technology enhances killing of cancer stem cells

Alchemia's subsidiary Alchemia Oncology today presented two posters at the American Association of Cancer Research (AACR) 101st Annual Meeting in Washington, DC. The data demonstrates the ability of the Company's HyACT tumour targeting technology to dramatically enhance the killing of cancer stem cells. These cells are highly resistant to treatment with chemotherapeutic drugs and are believed to be responsible for treatment failure and disease recurrence.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. David Benjamin Mark Ganetzky is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
David Benjamin Mark Ganetzky, MD
51 N 39th St, 7 Floor Mutch Bldg,
Philadelphia, PA 19104-2640

Ph: (215) 662-8777
David Benjamin Mark Ganetzky, MD
51 N 39th St, 7 Floor Mutch Bldg,
Philadelphia, PA 19104-2640

Ph: (215) 662-8777

News Archive

Protein profiling reveals new prostate cancer mechanisms

A study by the University of Tampere in Finland used protein profiling to find new prostate cancer mechanisms that are not shown by aberrations at the genomic level. Several new potential biomarkers of prostate cancer were also found.

Researchers develop experimental protocol to detect age-related memory disorders

By studying the aging of memory in the mouse, researchers in the Laboratoire Neurobiologie des Processus Adaptatifs have developed an experimental protocol that can detect age-related memory deficits at an early stage. They have shown that even at 10 months, which corresponds to a third of their life expectancy, some mice present with age-related memory disorders.

Cal-EPA intents to add BPA to state's list of chemicals known to cause cancer

The California Environmental Protection Agency signaled intent to add bisphenol A (BPA) to the state's list of chemicals known to cause cancer or birth defects, adding to evidence the chemical should be banned from food and beverage containers.

Alchemia's HyACT tumour targeting technology enhances killing of cancer stem cells

Alchemia's subsidiary Alchemia Oncology today presented two posters at the American Association of Cancer Research (AACR) 101st Annual Meeting in Washington, DC. The data demonstrates the ability of the Company's HyACT tumour targeting technology to dramatically enhance the killing of cancer stem cells. These cells are highly resistant to treatment with chemotherapeutic drugs and are believed to be responsible for treatment failure and disease recurrence.

Read more News

› Verified 6 days ago


Family Medicine Doctors in Philadelphia, PA

Srikar Vegesna,
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 2118 Cottman Ave, Philadelphia, PA 19149
Phone: 215-342-3020    Fax: 215-342-3653
Chelsea Tiffany Salas-tam,
Family Medicine
Medicare: Medicare Enrolled
Practice Location: 833 Chestnut St Ste 301, Philadelphia, PA 19107
Phone: 215-955-7190    
Meng-chao Lee, D.O.
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 7500 Central Ave Ste 104, Philadelphia, PA 19111
Phone: 215-742-0712    Fax: 215-742-5218
Carol Bowes-lawlor, D.O.
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 33 E Chestnut Hill Ave, Philadelphia, PA 19118
Phone: 215-753-9080    Fax: 215-753-8830
Dr. Seung Hee Hong, MD
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 2301 E Allegheny Ave, Suite 150, Philadelphia, PA 19134
Phone: 215-926-3535    Fax: 215-926-3536
Dr. Denise Hamilton Christian, M.D.
Family Medicine
Medicare: Medicare Enrolled
Practice Location: 251 E Bringhurst St, Philadelphia, PA 19144
Phone: 215-844-1020    Fax: 215-844-8147
Mara Leyzin, M.D.
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 8025 Castor Ave, Philadelphia, PA 19152
Phone: 215-745-9900    Fax: 215-745-9902

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.